CN101597582B - Culture medium of meningitis Neisseria - Google Patents
Culture medium of meningitis Neisseria Download PDFInfo
- Publication number
- CN101597582B CN101597582B CN2009100947104A CN200910094710A CN101597582B CN 101597582 B CN101597582 B CN 101597582B CN 2009100947104 A CN2009100947104 A CN 2009100947104A CN 200910094710 A CN200910094710 A CN 200910094710A CN 101597582 B CN101597582 B CN 101597582B
- Authority
- CN
- China
- Prior art keywords
- arginine
- culture medium
- sodium
- halfcystine
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a culture medium of meningitis Neisseria, which is characterized in that the culture medium consists of the following components: 3.0-8.0g/L of sodium chloride, 0.05-0.2g/L of potassium chloride, 1.0-6.0g/L of disodium hydrogen phosphate, 5-20g/L of L-glutamic acid, 0.01-0.1g/L of L-arginine, 0.001-0.01g/L of L-tryptophan, 0.005-0.030g/L of L-aminothiopropionic acid, 0.01-0.1g/L of calcium chloride, 0.001-0.008g/L of ferrous sulphate, 0.1-1/0 g/L of magnesium sulfate, 5.0-20.0 g/L of soya peptone and 5.0-20.0g/L of glucose. The invention is good for the growth and the metabolism of bacterium, can obtain higher output, has a wide material source, is free of structural constituents of the other animals, can effectively remove exogenous interference, simplifies technology on manufacture, is easy to operate, can effectively amplify the meningitis neisseria, and satisfies the mass production of vaccines.
Description
Technical field
The present invention relates to a kind of substratum, the improved culture medium of the fairly large cultivation of especially a kind of suitable Neisseria meningitidis belongs to biological technical field.
Technical background
Meningococcal meningitis is called for short epidemic meningitis, is by the caused acute respiratory transmissible disease of Neisserial Neisseria meningitidis.Because morbidity is anxious, PD is fast, the mortality ratio height, to Susceptible population---children's fulminant type case fatality rate can reach 40%~60%, thereby is subjected to generally attention both domestic and external always.
Though to Neisseria meningitidis research very early, and obtain certain achievement, the relevant report of its cultivation aspect seldom, and each producer maintains secrecy especially to its substratum.Kan Fangqi etc. (CN 101089190A) have invented a kind of nutrition blood culture medium, general sample mainly is provided and had used the patient specimen separation and Culture usefulness of microbiotic and sulfa drug, are not suitable for large scale culturing, have limitation.At present both at home and abroad the chocolate two anti-agar of more application are as isolation medium, and the separation test effect of this substratum is fine, but need use fresh defiber sheep blood when making, having material source is difficult for, the cost height, shortcomings such as complex manufacturing process are not suitable for increasing on a large scale bacterium and use.Present in addition meningitis substratum mostly is isolation medium, and its main purpose is separation and detects that so detect in order to separate, existing substratum will use antibiotic.
Because Neisseria meningitidis is very harsh to environment requirement, its growth is not only relevant with the bacterial classification self character, as belong to obligate aerobe, and often, thalline causes self cracking death in the culturing process because of producing autolytic enzyme, and must give suitable medium and just can make its good growth metabolism.Therefore, be necessary that fully development and exploitation are fit to industrial scale production, and material source is wide, price is low, can avoid thalline to produce the substratum of the adaptation Neisseria meningitidis growth metabolism of autolytic enzyme.
Summary of the invention
The present invention provides a kind of and can guarantee that the Neisseria meningitidis growth is vigorous just for overcoming the prior art above shortcomings, carries out eubolism, can provide again to increase bacterium on a large scale to be used to produce the culture medium of meningitis Neisseria of vaccine.
The present invention finishes by following technical proposal: a kind of culture medium of meningitis Neisseria is characterized in that being made up of following component:
Sodium-chlor 3.0~8.0g/L Repone K 0.05~0.2g/L
Sodium phosphate dibasic 1.0~6.0g/L L-L-glutamic acid 5~20g/L
L-arginine 0.01~0.1g/L L-tryptophane 0.001~0.01g/L
L-halfcystine 0.005~0.030g/L calcium chloride 0.01~0.1g/L
Ferrous sulfate 0.001~0.008g/L sal epsom 0.1~1.0g/L
Soy peptone 5.0~20.0g/L glucose 5.0~20.0g/L.
Substratum provided by the invention prepares by following method:
A, with sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-halfcystine, calcium chloride, ferrous sulfate, soy peptone mixture with dissolved in distilled water after, constant volume, regulate pH to 7.2-7.4, at 113~117 ℃, 0.06 under~0.08MPa the condition, sterilization 15~25min;
B, with L-tryptophane, sal epsom, glucose mixture with the 15mL dissolved in distilled water after, after the 0.2 μ m disposable filter filtration sterilization, add in the mixture of A step of high pressure degerming, liquid nutrient medium.
Substratum provided by the invention has following characteristics: contain the required nutritional requirement of Neisseria meningitidis growth metabolism, the Neisseria meningitidis of purifying is used for increasing on a large scale, wherein L-L-glutamic acid is one of primary amino acid of nitrogen metabolism in the organism, Neisseria meningitidis does not have the sulphate reducing ability, so will allocate the L-halfcystine that belongs to reduced form sulfide into, the L-arginine is the moiety of urea cycle in the bacterium, the effect with the nitrogen equilibrium kept; Calcium ion in the calcium chloride can promote growth; Magnesium ion in the sal epsom can shorten lag phase; Iron ion in the ferrous sulfate can influence the virulence of bacterial strain and help the expansion of bacterium colony; Glucose helps the breeding growth of Neisseria meningitidis.
The present invention compared with prior art has following advantage and effect: the invention provides a kind of extensive enrichment medium that can be used for production of vaccine, material that is adopted and technology all are final purpose with the production of vaccine.Adopt above-mentioned culture medium culturing Neisseria meningitidis, the growth metabolism that helps bacterium, with other substratum mutually specific energy obtain high yield, and material source is extensive, do not contain other animal tissues's compositions, as serum etc., can effectively get rid of the interference of external source, the bacterium that can obtain higher degree on producing is used for production of vaccine, make work simplification, easy handling uses liquid nutrient medium provided by the invention to carry out large scale culturing, the Neisseria meningitidis that can effectively increase, the bacterium that obtains purifying is for production of vaccine.
Embodiment
Embodiment 1
Get the raw materials ready by following prescription:
Sodium-chlor 5.8g Repone K 0.09g
Sodium phosphate dibasic 2.6g L-L-glutamic acid 15.0g
L-arginine 0.03g L-tryptophane 0.0025g
L-halfcystine 0.012g calcium chloride 0.021g
Ferrous sulfate 0.002g sal epsom 0.6g
Soy peptone 15.0g glucose 10.0g
Make through following method:
A, with sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-halfcystine, calcium chloride, ferrous sulfate, soy peptone mixture with dissolved in distilled water after, be settled to 1L, regulate pH to 7.4, at 113 ℃, 0.08MPa sterilization 15min down;
B, with L-tryptophane, sal epsom, glucose mixture with the 15mL dissolved in distilled water after, after the 0.2 μ m disposable filter filtration sterilization, add in the mixture of A step of high pressure degerming, liquid nutrient medium.
Embodiment 2
Get the raw materials ready by following prescription:
Sodium-chlor 3.0g Repone K 0.05g
Sodium phosphate dibasic 6.0g L-L-glutamic acid 5.0g
L-arginine 0.01g L-tryptophane 0.001g
L-halfcystine 0.005g calcium chloride 0.01g
Ferrous sulfate 0.008g sal epsom 1.0g
Soy peptone 5.0g glucose 5.0g
Make through following method:
A, with sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-halfcystine, calcium chloride, ferrous sulfate, soy peptone mixture with dissolved in distilled water after, be settled to 1L, regulate pH to 7.2, at 117 ℃, 0.06MPa sterilization 15min down;
B, with L-tryptophane, sal epsom, glucose mixture with the 15mL dissolved in distilled water after, after the 0.2 μ m disposable filter filtration sterilization, add in the mixture of A step of high pressure degerming, liquid nutrient medium.
Embodiment 3
Get the raw materials ready by following prescription:
Sodium-chlor 8.0g Repone K 0.2g
Sodium phosphate dibasic 2.0g L-L-glutamic acid 20.0g
L-arginine 0.1g L-tryptophane 0.01g
L-halfcystine 0.03g calcium chloride 0.1g
Ferrous sulfate 0.001g sal epsom 0.1g
Soy peptone 20.0g glucose 20.0g
Make through following method:
A, with sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-halfcystine, calcium chloride, ferrous sulfate, soy peptone mixture with dissolved in distilled water after, be settled to 1L, regulate pH to 7.4, at 115 ℃, 0.07MPa sterilization 20min down;
B, with L-tryptophane, sal epsom, glucose mixture with the 15mL dissolved in distilled water after, after the 0.2 μ m disposable filter filtration sterilization, add in the mixture of A step of high pressure degerming, liquid nutrient medium.
The Neisseria meningitidis amplification culture
Claims (2)
1. a culture medium of meningitis Neisseria is characterized in that being made up of following component: sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-tryptophane, L-halfcystine, L-halfcystine L-arginine, calcium chloride, ferrous sulfate, sal epsom, soy peptone, glucose, distilled water; Sodium-chlor 3.0~8.0g/L wherein, Repone K 0.05~0.2g/L, Sodium phosphate dibasic 1.0~6.0g/L, L-L-glutamic acid 5~20g/L, L-arginine 0.01~0.1g/L, L-tryptophane 0.001~0.01g/L, L-halfcystine 0.005~0.030g/L, calcium chloride 0.01~0.1g/L, ferrous sulfate 0.001~0.008g/L, sal epsom 0.1~1.0g/L, soy peptone 5.0~20.0g/L, glucose 5.0~20.0g/L.
2. culture medium of meningitis Neisseria according to claim 1 is characterized in that it prepares by following method:
A, with sodium-chlor, Repone K, Sodium phosphate dibasic, L-L-glutamic acid, L-arginine, L-halfcystine, calcium chloride, ferrous sulfate, soy peptone mixture with dissolved in distilled water after, constant volume, regulate pH to 7.2-7.4, at 113~117 ℃, 0.06 under~0.08MPa the condition, sterilization 15~25min;
B, with L-tryptophane, sal epsom, glucose mixture with the 15mL dissolved in distilled water after, after the 0.2 μ m disposable filter filtration sterilization, add in the mixture of A step of high pressure degerming, liquid nutrient medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100947104A CN101597582B (en) | 2009-07-10 | 2009-07-10 | Culture medium of meningitis Neisseria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100947104A CN101597582B (en) | 2009-07-10 | 2009-07-10 | Culture medium of meningitis Neisseria |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101597582A CN101597582A (en) | 2009-12-09 |
CN101597582B true CN101597582B (en) | 2011-04-06 |
Family
ID=41419181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100947104A Active CN101597582B (en) | 2009-07-10 | 2009-07-10 | Culture medium of meningitis Neisseria |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101597582B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR102012013110A2 (en) * | 2012-05-31 | 2014-05-27 | Cristalia Prod Quimicos Farm | CULTURE FOR CLOSTRIDIUM BACTERIA FREE OF ANIMAL COMPONENTS AND PROCESS FOR SUPERVISOR PRODUCTION CONTAINING ONE OR MORE PROTEASES WITH COLLAGENOLYTIC AND GELATINOLYTIC ACTIVITY |
CN108690816A (en) * | 2017-04-12 | 2018-10-23 | 成都生物制品研究所有限责任公司 | A kind of the non-animal source culture medium and its cultural method of A groups of neisseria meningitis inflammation coccus |
RU2019140344A (en) * | 2017-05-17 | 2021-06-17 | Мсд Веллком Траст Хиллеман Лабораторис Пвт. Лтд. | OBTAINING BACTERIAL POLYSACCHARIDES |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040229319A1 (en) * | 2003-05-16 | 2004-11-18 | Egen Richard C. | Animal component free meningococcal polysaccharide fermentation and seedbank development |
WO2005103230A2 (en) * | 2004-04-22 | 2005-11-03 | Chiron Srl | Soy peptone as a nitrogen source in preparing meningococcal conjugates |
CN101089190A (en) * | 2006-06-16 | 2007-12-19 | 阚方琦 | Nutrition blood culture medium |
-
2009
- 2009-07-10 CN CN2009100947104A patent/CN101597582B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040229319A1 (en) * | 2003-05-16 | 2004-11-18 | Egen Richard C. | Animal component free meningococcal polysaccharide fermentation and seedbank development |
WO2005103230A2 (en) * | 2004-04-22 | 2005-11-03 | Chiron Srl | Soy peptone as a nitrogen source in preparing meningococcal conjugates |
CN101089190A (en) * | 2006-06-16 | 2007-12-19 | 阚方琦 | Nutrition blood culture medium |
Non-Patent Citations (1)
Title |
---|
EMILO WEISS et al.simplified method for the production of carbohydrate antigen from Neisseria meningtiditidis.《APPLIED MICROBIOLOGY》.1969,第18卷(第5期),全文. * |
Also Published As
Publication number | Publication date |
---|---|
CN101597582A (en) | 2009-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2565180T3 (en) | Process for the preparation of high purity polysalic acid | |
CN110628684B (en) | Lactobacillus enrichment agent and application thereof in high-density fermentation of lactobacillus | |
CN102925504B (en) | Method and fermentation culture medium used for synthesizing gamma-aminobutyric acid through microbial fermentation | |
CN101838672A (en) | Method for producing gamma-amino butyric acid by using immobilized lactobacillus plantarum | |
CN101597582B (en) | Culture medium of meningitis Neisseria | |
CN106755186B (en) | Ochrobactrum intermedium exopolysaccharide and application thereof in soil improvement | |
RU2433170C1 (en) | Nutrient liquid medium for culturing plague microbe of vaccine strain eb | |
RU2006127216A (en) | METHOD FOR PRODUCING SELENGE-CONTAINING BIOLOGICALLY ACTIVE ADDITIVE | |
CN109929897A (en) | A kind of promotion HAU-M1 photosynthetic bacteria flora produces culture medium and its application of hydrogen | |
CN103880194B (en) | The preparation technology of a kind of microbiological water purification agent and the use of this water purification microbial inoculum | |
CN103923936A (en) | Construction of arginase production engineering bacteria and application of arginase production engineering bacteria in production of L-ornithine | |
CN108220343A (en) | The fermentation process of calcium transformation ratio and antioxygenic property in a kind of raising lamb bone meal enzymolysis liquid | |
CN105175275B (en) | A kind of isolation and purification method of L ornithine | |
CN111621528A (en) | Method for biologically synthesizing ethanolamine | |
CN105002228B (en) | A method of preparing L-Orn by raw material of arginine | |
CN109644778A (en) | A kind of edible fungus liquid fermentation medium and preparation method thereof | |
MD3101G2 (en) | Process for Spirulina platensis biomass obtaining | |
CN108977482A (en) | A kind of preparation method of aerosporin | |
CN104830923B (en) | A kind of method for producing L-Glutamine from Pidolidone biotransformation method using lactobacillus thermophilus | |
CN102199636A (en) | Efficient preparation process of gamma-amino-n-butyric acid | |
RU2425866C1 (en) | Nutrient medium for submerged cholera vibrio cultivation | |
CN102533577B (en) | Type 2 streptococcus suis high-intensity fermentation medium and application | |
Dubencovs et al. | Medium formulation and fed-batch cultivation of Methylosinus trichosporium | |
CN106694521B (en) | One metal ion species strengthen method of the thermophilic lysis bacterium for antibiotic bacterium dregs minimizing | |
CN110452838A (en) | A kind of CRM197 bacterium culture medium, preparation method and fermentation culture method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |